Finland-based molecular diagnostics firm Mobidiag has received CE-IVD marking for a proprietary system called Amplidiag Easy, which enables nucleic acid extraction and PCR setup directly from stool samples.

The device enables quicker sample to result time through an automated solution, which runs directly from stool primary sample tubes to PCR setup, eliminating the requirement for manual setup.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The system is equipped with the Amplidiag Analyzer software, which enables direct transfer of data between the Amplidiag Easy and PCR instruments.

"It allows labs to overcome their main challenges: improve cost-efficiency by reducing hands-on-time and increase sample throughput with automation."

Mobidiag chief executive officer Tuomas Tenkanen said: “Amplidiag Easy sets a new standard for multiplex assays in gastrointestinal infections as it allows labs to overcome their main challenges: improve cost-efficiency by reducing hands-on-time and increase sample throughput with automation.

“In that perspective, we are very pleased to see the adoption of our first platform by the renowned Finnish lab Yhtyneet Medix Laboratoriot for their routine diagnostic screen.”

See Also:

The new system complements the range of Mobidiag devices designed to perform IVD tests for gastrointestinal infections, by enabling simultaneous screening of relevant gastrointestinal pathogens.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The PCR technology of the devices results in optimal performance, enables high-volume screening use and is cost-effective in mid-sized to large laboratory settings.

Founded in 2000, Mobidiag designs devices for the diagnosis of infectious diseases, which fulfill high-volume and demand testing.

The firm further plans to launch Novodiag platform and associated panels, allowing a fully automated solution and a platform for smaller volumes and labs.